tiprankstipranks
Ajanta Pharma Limited (IN:AJANTPHARM)
:AJANTPHARM
India Market
AJANTPHARM
Ajanta Pharma Limited
RESEARCH TOOLSreports

Ajanta Pharma Limited (AJANTPHARM) Ratios

5 Followers

Ajanta Pharma Limited Ratios

IN:AJANTPHARM's free cash flow for Q2 2026 was ₹0.50. For the 2026 fiscal year, IN:AJANTPHARM's free cash flow was decreased by ₹ and operating cash flow was ₹0.25. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 2.93 2.85 3.05 2.49 3.50
Quick Ratio
 2.23 1.95 2.12 1.77 2.28
Cash Ratio
 0.08 0.18 0.14 0.29 0.32
Solvency Ratio
 0.87 0.87 0.89 0.56 1.06
Operating Cash Flow Ratio
 0.24 1.16 0.88 0.69 0.87
Short-Term Operating Cash Flow Coverage
 1.35 446.81 526.89 4.40K 2.08K
Net Current Asset Value
₹ 20.36B₹ 16.18B₹ 16.60B₹ 15.43B₹ 14.73B
Leverage Ratios
Debt-to-Assets Ratio
 0.04 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 0.06 0.01 <0.01 0.01 <0.01
Debt-to-Capital Ratio
 0.05 0.01 <0.01 0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 <0.01 <0.01
Financial Leverage Ratio
 1.31 1.32 1.30 1.38 1.24
Debt Service Coverage Ratio
 5.24 46.54 110.20 120.29 80.96
Interest Coverage Ratio
 101.27 54.44 272.92 121.76 76.63
Debt to Market Cap
 <0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
 21.27 5.44 3.37 3.24 2.72
Net Debt to EBITDA
 0.10 -0.10 -0.07 -0.33 -0.17
Profitability Margins
Gross Profit Margin
69.29%75.43%73.50%70.34%73.00%
EBIT Margin
25.67%26.37%26.64%20.07%28.00%
EBITDA Margin
28.93%29.51%29.86%23.55%31.80%
Operating Profit Margin
39.04%24.60%46.75%19.00%23.80%
Pretax Profit Margin
25.29%25.92%26.47%19.91%27.69%
Net Profit Margin
19.73%20.06%19.39%15.71%21.70%
Continuous Operations Profit Margin
19.73%20.06%19.39%15.71%21.70%
Net Income Per EBT
78.05%77.40%73.27%78.90%78.36%
EBT Per EBIT
64.76%105.38%56.61%104.81%116.36%
Return on Assets (ROA)
17.89%18.35%17.60%12.57%17.57%
Return on Equity (ROE)
26.06%24.28%22.88%17.35%21.83%
Return on Capital Employed (ROCE)
44.48%28.08%52.58%20.09%22.93%
Return on Invested Capital (ROIC)
33.17%21.66%38.40%15.81%17.94%
Return on Tangible Assets
18.02%18.52%17.65%12.59%17.61%
Earnings Yield
3.00%2.81%2.90%3.80%4.55%
Efficiency Ratios
Receivables Turnover
 3.55 3.88 3.38 3.54 3.22
Payables Turnover
 3.67 2.48 2.41 2.63 2.71
Inventory Turnover
 1.94 1.25 1.35 1.36 1.12
Fixed Asset Turnover
 2.60 2.42 2.45 2.20 1.99
Asset Turnover
 0.91 0.91 0.91 0.80 0.81
Working Capital Turnover Ratio
 4.60 2.49 2.38 2.26 2.19
Cash Conversion Cycle
 191.25 239.71 227.63 232.23 304.30
Days of Sales Outstanding
 102.92 94.10 108.13 103.07 113.34
Days of Inventory Outstanding
 187.76 292.69 271.09 268.15 325.63
Days of Payables Outstanding
 99.43 147.08 151.59 138.99 134.67
Operating Cycle
 290.68 386.79 379.22 371.23 438.97
Cash Flow Ratios
Operating Cash Flow Per Share
 22.73 92.45 62.35 61.80 43.35
Free Cash Flow Per Share
 8.84 67.05 50.24 48.18 31.87
CapEx Per Share
 13.88 25.40 12.10 13.62 11.48
Free Cash Flow to Operating Cash Flow
 0.39 0.73 0.81 0.78 0.74
Dividend Paid and CapEx Coverage Ratio
 1.64 1.73 0.99 3.00 2.43
Capital Expenditure Coverage Ratio
 1.64 3.64 5.15 4.54 3.78
Operating Cash Flow Coverage Ratio
 1.15 24.40 22.25 22.22 22.45
Operating Cash Flow to Sales Ratio
 0.06 0.25 0.19 0.21 0.17
Free Cash Flow Yield
0.33%2.56%2.24%3.99%2.64%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 33.39 35.60 34.54 26.34 21.96
Price-to-Sales (P/S) Ratio
 6.59 7.14 6.70 4.14 4.77
Price-to-Book (P/B) Ratio
 7.85 8.64 7.90 4.57 4.79
Price-to-Free Cash Flow (P/FCF) Ratio
 306.67 39.04 44.55 25.09 37.88
Price-to-Operating Cash Flow Ratio
 119.31 28.31 35.90 19.56 27.85
Price-to-Earnings Growth (PEG) Ratio
 7.86 2.64 0.84 -1.59 2.24
Price-to-Fair Value
 7.85 8.64 7.90 4.57 4.79
Enterprise Value Multiple
 22.88 24.10 22.36 17.24 14.81
Enterprise Value
 340.00B 326.34B 280.93B 151.93B 154.71B
EV to EBITDA
 22.86 24.10 22.36 17.24 14.81
EV to Sales
 6.61 7.11 6.68 4.06 4.71
EV to Free Cash Flow
 307.77 38.88 44.41 24.61 37.44
EV to Operating Cash Flow
 119.74 28.20 35.78 19.19 27.53
Tangible Book Value Per Share
 342.08 299.09 282.15 263.84 251.07
Shareholders’ Equity Per Share
 345.38 302.81 283.31 264.44 251.77
Tax and Other Ratios
Effective Tax Rate
 0.22 0.23 0.27 0.21 0.22
Revenue Per Share
 411.50 366.50 334.25 292.12 253.29
Net Income Per Share
 81.21 73.53 64.82 45.89 54.97
Tax Burden
 0.78 0.77 0.73 0.79 0.78
Interest Burden
 0.98 0.98 0.99 0.99 0.99
Research & Development to Revenue
 0.01 0.00 0.05 0.06 0.06
SG&A to Revenue
 0.23 0.24 0.03 0.21 0.20
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 0.23 1.26 0.96 1.06 0.62
Currency in INR